Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database
- PMID: 33904857
- PMCID: PMC8080152
- DOI: 10.1001/jamainternmed.2021.2219
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database
Abstract
This disproportionality analysis uses the World Health Organization pharmacovigilance database to explore the potential safety signal of facial paralysis after COVID-19 vaccination.
Conflict of interest statement
Figures
Comment in
-
Caution in Interpreting Facial Paralysis Data to Understand COVID-19 Vaccination Risks.JAMA Intern Med. 2021 Oct 1;181(10):1420. doi: 10.1001/jamainternmed.2021.4333. JAMA Intern Med. 2021. PMID: 34398185 No abstract available.
Similar articles
-
Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.J Peripher Nerv Syst. 2022 Sep;27(3):206-214. doi: 10.1111/jns.12507. Epub 2022 Jul 6. J Peripher Nerv Syst. 2022. PMID: 35751472 Free PMC article.
-
Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.J Med Virol. 2024 Jul;96(7):e29792. doi: 10.1002/jmv.29792. J Med Virol. 2024. PMID: 38993028
-
Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database.Clin Drug Investig. 2020 Sep;40(9):883-889. doi: 10.1007/s40261-020-00952-0. Clin Drug Investig. 2020. PMID: 32696320 Free PMC article.
-
Safety profile of COVID-19 vaccines, preventive strategies, and patient management.Expert Rev Vaccines. 2022 Aug;21(8):1087-1095. doi: 10.1080/14760584.2022.2078311. Epub 2022 May 19. Expert Rev Vaccines. 2022. PMID: 35559718 Review.
-
Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches.Expert Opin Drug Saf. 2024 Oct;23(10):1215-1225. doi: 10.1080/14740338.2024.2387322. Epub 2024 Sep 24. Expert Opin Drug Saf. 2024. PMID: 39115010 Review.
Cited by
-
AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.Hum Vaccin Immunother. 2024 Dec 31;20(1):2426319. doi: 10.1080/21645515.2024.2426319. Epub 2024 Nov 21. Hum Vaccin Immunother. 2024. PMID: 39569615 Free PMC article.
-
Lower Motor Neuron Facial Palsy Following COVID-19 Infection and COVID-19 AZD1222 Vaxzervria (AstraZeneca) Vaccine Administration: Two Case Reports.Int Med Case Rep J. 2024 Mar 23;17:215-219. doi: 10.2147/IMCRJ.S453158. eCollection 2024. Int Med Case Rep J. 2024. PMID: 38544683 Free PMC article.
-
Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.J Korean Med Sci. 2024 Mar 4;39(8):e76. doi: 10.3346/jkms.2024.39.e76. J Korean Med Sci. 2024. PMID: 38442719 Free PMC article.
-
Understanding Sociodemographic Factors and Reasons Associated with COVID-19 Vaccination Hesitance among Adults in Tanzania: A Mixed-Method Approach.Am J Trop Med Hyg. 2023 Sep 11;109(4):895-907. doi: 10.4269/ajtmh.23-0229. Print 2023 Oct 4. Am J Trop Med Hyg. 2023. PMID: 37696518 Free PMC article.
-
Sudden sensorineural hearing loss after receiving an inactivated viral vaccine, Sinopharm: Two-case report.SAGE Open Med Case Rep. 2023 Aug 10;11:2050313X231191237. doi: 10.1177/2050313X231191237. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37576350 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
